Evogene Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was USD 0.641 million compared to USD 0.237 million a year ago. Net loss was USD 6.27 million compared to USD 8.28 million a year ago.

Basic loss per share from continuing operations was USD 0.15 compared to USD 0.2 a year ago.